Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2024

Genmab — Februar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #1482

    i onkologi er det noget så usexet som ADC'erne, der har fået comeback

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #1483

      Ja underligt nok. Moden svinger.

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1484

        10 stocks with huge cash position vs capitalisation https://twitter.com/aifininsights/status/1762538260805329352

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #1485

          Zai Lab will focus on the following strategic priorities in 2024 to drive innovation in China and beyond:
          Planned China submissions: [ ]
          Tisotumab vedotin in second-line+ cervical cancer

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #1486

            Zai Lab to submit an NDA to the NMPA in second-line+ cervical cancer. https://www.businesswire.com/news/home/20240227802106/en/Zai-Lab-Announces-Full-Year-2023-Financial-Results-and-Recent-Corporate-Updates

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #1487

              Capital Increase in Genmab as a Result of Employee Warrant Exercise https://www.proinvestor.com/investornyt/1124046/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #1488

                Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/1124047/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons

                1 Reply Last reply
                0
                • V Offline
                  V Offline
                  Vougeot
                  wrote on sidst redigeret af
                  #1489

                  Vi skal på et tidspunkt ned i 1892, så gap'et kan bliver lukket, øv 🙂

                  1 Reply Last reply
                  0
                  • royalR Offline
                    royalR Offline
                    royal
                    wrote on sidst redigeret af
                    #1490

                    Så er det jo easy money. Sælg nu og vent til 1892. 🙂

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #1491

                      Fedt fedt fedt er vist det eneste der rykker.

                      1 Reply Last reply
                      0
                      • royalR Offline
                        royalR Offline
                        royal
                        wrote on sidst redigeret af
                        #1492

                        På den anden side kan kursen også 2200 inden nogen når at sige Bjarne bruger briller.

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #1493

                          Ja når momentum vender skal det nok gå stærkt opad

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1494

                            i don't understand why Genmab does not benefit from this weight-loss hype...

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1495

                              diarrhea, nausea, vomiting..., I mean it should be clear by now how easy it is to loose weigth just by holding Genmab shares...

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #1496

                                ...except the organization is putting on wheight at an alarming rate

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #1497

                                  Karakterbogen er landet - Så er det tid til at give karakterer til nogle af de største danske selskaber. Hør blandt andet om Mærsk, ISS, Novo Nordisk, Vestas, Genmab, Rockwool, Carlsberg, Bavarian Nordic og til sidst sluttes der af med en gennemgang af Zealand Pharma https://www.proinvestor.com/boards/119016

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1498

                                    Victory for patients with incurable disease after NHS treatment U-turn [ Daratumumab in combination for treating
                                    newly diagnosed systemic amyloid light-chain
                                    amyloidosis ] https://inews.co.uk/news/health/al-amyloidosis-treatment-u-turn-nice-nhs-2929429

                                    1 Reply Last reply
                                    0
                                    • JørgenVarnæsJ Offline
                                      JørgenVarnæsJ Offline
                                      JørgenVarnæs
                                      wrote on sidst redigeret af
                                      #1499

                                      any chance GEN is going short on the stock purchase program?

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Pensionisten
                                        wrote on sidst redigeret af
                                        #1500

                                        .-D

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Pensionisten
                                          wrote on sidst redigeret af
                                          #1501

                                          😄

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper